For the second time, U.S. health regulators have denied approval for the use of Gardasil in women, ages 27 to 45. Officials want more long term clinical data. Merck’s Gardasil is said to protect against human papillomavirus (HPV), which can cause cervical cancer. Following the denial Merck’s shares dropped 79 cents. Merck is also pushing Gardasil for use among men; Reuters reports.
Now, Gardasil is no wonder drug! The U.S. Food and Drug Administration has received 7,802 instances of people suffering an adverse reaction to Gardasil and the vaccine only protects against 4 of the 100 strains of HPV. It also killed a 17-year old girl from New York. Not to mention, this spring the FDA ordered Merck clean up a manufacturing plant where Gardasil is produced.
Image credit: christopherdale